USPTO serial 79234304
OXFORD NANOPORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- YOO, JEANE
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OXFORD NANOPORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software; software; software for running an e-commerce platform; software for use in analysing, transmitting and receiving data via a global communications network; software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; computer operating software; operating system software; operating software for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; sensors; micro-array chips; electronic sensing apparatus; scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, supervision, life-saving and teaching apparatus and instruments; apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, sensing, preparation, testing and manipulation, optical or electrochemical analysis, medical diagnosis, and for the measurement of ions (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, sensing, preparation, testing and manipulation, optical or electrochemical analysis, medical diagnosis, and for the measurement of ions (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing; apparatus for the analysis of polynucleic acid sequences; apparatus and instruments for the analysis of nucleic and polynucleic acids; apparatus and instruments for the analysis of proteins; apparatus and instruments for analysis of genetic information, genomic information and proteomic information; apparatus and instruments for use in laboratory analysis; diagnostic and testing apparatus, not for medical purposes; monitoring apparatus and instruments; computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; scientific apparatus and instruments; apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments; apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; instruments and apparatus for the display of information obtained from scientific equipment; silicon chips; DNA chips; analyte detector chips; biosensor chips; cartridges (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); batteries; rechargeable batteries; chargers for batteries; power packs; computer docking stations; apparatus for connecting and charging portable digital electronic devices; testing apparatus incorporating chemical or biological reagents (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); reaction units containing chemical or biological reagents; nanopore sensing devices (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Surgical, medical and veterinary apparatus and instruments; medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; portable medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; liquid biopsy devices; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes; portable diagnostic apparatus for medical or veterinary purposes; testing apparatus for medical or veterinary purposes; portable testing apparatus for medical or veterinary purposes; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, for medical purposes; nanopore sensing devices (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); parts and fittings for all the aforesaid goods | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto; industrial analysis and research services; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services; synthesis of chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; scientific research for medical or veterinary purposes; genome, DNA, RNA and nucleic acid, oligosaccharide, protein and peptide synthesising services; chemical compound and small molecule synthesising services; DNA and RNA and polynucleic acid sequencing services; protein sequencing services; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services; DNA and polynucleic acid testing services; genome sequencing services; analysis and evaluation of data, including scientific and medical data (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); computerised analysis of data; overseeing, monitoring and managing scientific and medical experiments and tests (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); overseeing, monitoring and managing the analysis and evaluation of scientific and medical data (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); design of scientific experiments; analysis of data generated by scientific and medical experiments and tests (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests (term considered too vague by the International Bureau - rule 13 (2) (b) of the Common Regulations); scientific and medical research and development services; technical data analysis and evaluation services; electronic data storage services; application service provider (ASP) services for providing access to computer software applications installed or downloaded onto data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 14, 2020 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 29, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 29, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 6, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 20, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 20, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2019 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 29, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 21, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 3, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 3, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 14, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |